The mechanism of autoantibody formation to cartilage in rheumatoid arthritis: Possible cross-Rraction of antibodies to dietary collagens with autologous type II collagen

Clinical Immunology and Immunopathology

Volumn 79, Issue 2, 1996, Pages 142-154

  Terato, Kuniaki ^a   Dearmey, Deborah A ^d   Ye, Xiu J ^c   Griffiths, Marie M ^a,b   Cremer, Michael A ^c,d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COLLAGEN TYPE 1; COLLAGEN TYPE 2; EPITOPE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; CONTROLLED STUDY; DIET; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0029965882     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0061     Document Type: Article

References (66)

1. Gregersen, P., Silver, J., and Winchester, R., The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30, 1205-1213, 1987
2. Stastny, P., Ball, E., Kahn, M., Olsen, N., Pincus, T., and Gao, X., HLA-DR4 and other genetic markers in rheumatoid arthritis. Br. J. Rheumatol. 27, 132-138, 1988.
3. Wordsworth, B., Lanchbury, J., Sakkas, L., Welsh, K., Panayi, G., and Bell, J., HLA-DR4 subtype frequency in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus with the human leukocyte antigen class II region. Proc. Natl. Acad. Sci. USA. 86, 10049-10053, 1989.
4. Kaufmann, S., Heatshock proteins: A link between rheumatoid arthritis and infection. Curr. Opin. Rheumatol. 2, 430-435, 1990.
5. Roudier, J., Rhodes, G., and Petersen, J., A Hypothesis: The Epstein - Barr virus glycoprotein gp110, a molecular link between HLA DR4, HLA DR1, and rheumatoid arthritis. Scand. J. Immunol. 27, 367-371, 1988.
6. Drake, C., and Kotzin B., Superantigens: Biology, immunology, and potential role in disease. J. Clin. Immunol. 12, 149-162, 1992.
7. Paliard, X., West, S. G., Lafferty, J. A., Clements, J. R., Kappler, J. W., Marrack, P., and Kotzin, B. L., Evidence for the effects of a superantigen in rheumatoid arthritis. Science 253, 325-329, 1991.
8. Perez-Maceda, B., Lopez-Bote, J. P., Langa, C., and Bernabeu, C., Antibodies to dietary antigens in rheumatoid arthritis-possible molecular mimicry mechanism. Clin. Chim. Acta 203, 153-165, 1991.
9. Terato, K., Shimozuru, Y., Katayama, K., Takemitsu, Y., Yamashita, I., Miyatsu, M., Sagara, M., Miyasaka, N., and Nagai, Y., Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum. 33, 1493-1500, 1990.
10. Trentham, D. E., Townes, A. S., and Kang, A. H., Autoimmunity to type II collagen: An experimental model of arthritis. J. Exp. Med. 146, 857-868, 1977.
11. Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A., and Mosedale, B., Immunization against heterologous type II collagen includes arthritis in mice. Nature 283, 666-668, 1980.
12. Griffiths, M. M., Eichwald, E. J., Martin, J. H., Smith, C. B., and Dewitt, C. W., Immunogenetic control of experimental type II collagen-induced arthritis. I. susceptibility and resistance among inbred strains of rats. Arthritis Rheum. 24, 781-789, 1981.
13. Cathcart, E. S., Hayes, K. C., Gonnerman, W. A., Lazzari, A. A., and Franzblau, C., Experimental arthritisin a nonhuman primate. I. Induction by bovine type II collagen. Lab Invest. 54, 26-31, 1986.
14. Andriopoulos, N. A., Mestecky, J., Miller, E. J., and Bradley, E. L., Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis. Arthritis Rheum. 19, 613-617, 1976.
15. Greenbury, C. L., and Skingle, J. Anti-cartilage antibody. J. Clin. Pathol. 32, 826-831, 1979.
16. Beard, H. K., Ryvar, R., Skingle, J., and Greenbury, C. L. Anticollagen antibodies in sera from rheumatoid arthritis patients. J Clin Pathol. 33, 1077-1081, 1980.
17. Andriopoulos, N. A., Mestecky, J., Miller, E. J., and Benett, J. C., Antibodies to human native and denatured collagen in synovial fluid of patients with rheumatoid arthritis. Clin. Immunol. Immunopathol. 6, 209-212, 1976.
18. Clague, R. B., and Moore, L. J., IgG and IgM antibody to native type II collagen in rheumatoid arthritis serum and synovial fluid. Evidence for the presence of collagen-anticollagen immune complexes in synovial fluid. Arthritis Rheum. 27, 1370-1377, 1984.
19. Jasin, H. E., Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 28, 241-248, 1985.
20. Tarkowski, A., Klareskog, L., Carlsten, H., Herberts, P., and Koopman, W. J., Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum. 32, 1087-1092, 1989.
21. Wooley, P. H., Luthra, H. S., Singh, S., Huse, A., Stuart, J. M., and David, C. S., Passive transfer of arthritis in mice by human anti-type II collagen antibody. Mayo Clin. Proc. 59, 737-743, 1984.
22. Steffen, C., Consideration of pathogenesis of rheumatoid arthritis as collagen autoimmunity. Z. Immun.-Forsch. 139, 219-227, 1970.
23. 14C-radioimmunoassy. Arthritis Rheum. 21, 243-248, 1978.
24. 125I-radioimmunoassay. Arthritis Rheum. 26, 832-840, 1983.
25. Clague, R. B., Firth, S. A., Holt, P. J. L., Skingle, J., Greenbury, C. L., and Webley, M., Serum antibodies to type II collagen in rheumatoid arthritis: Comparison of 6 immunological methods and clinical features. Ann. Rheum. Dis. 42, 537-544, 1983.
26. Gosslau, B., and Barrach, H. J., Enzyme-linked immunosorbent microassay for quantification of specific antibodies to collagen type I, II, III, J. Immunol. Methods. 29, 71-77, 1979.
27. Rowley, M., Tait, B., MacKay, I. R., Cunningham, T., and Phillips, B. Collagen antibodies in rheumatoid arthritis. Significance of antibodies to denatured collagen and their association with HLA-DR4. Arthritis Rheum. 29, 174-184, 1986.
28. Banerjee, S., Luthra, H. S., Moore, S. B., and O'Fallon, W. M., Serum IgG anti-type II collagen antibodies in rheumatoid arthritis: association with DR4 and lack of clinical correlation. Clin Exp. Rheumatol. 6, 373-380, 1988.
29. Dyer, P. A., Clague, R. B., Klouda, P. T., Firth, S., Harris, R., and Holt, P. J. L., HLA antigens in patients with rheumatoid arthritis and antibodies to type II collagen. Tissue Antigens 20, 394-396, 1982.
30. Klimiuk, P. S., Clague, R. B., Grennan, D. M., and Dyer, P. A. Autoimmunity to native type II collagen: A distinct genetic subset of rheumatoid arthritis. J. Rheumatol. 12, 865-870, 1985.
31. Wooley, P. H., Luthra, H. S., O'Duffy, J. D., Bunch, T. W., Moore, S. B., and Stuart, J. M. Anti-type II collagen antibodies in rheumatoid arthritis. The influence of HLA phenotype. Tissue Antigens 23, 263-269, 1984.
32. Morgan, K., Clague, R. B., Collins, I., Ayad, S., Phinn, S. D., and Holt, P. J. L., A longitudinal study of anticollagen antibodies in patients with rheumatoid arthritis. Arthritis Rheum. 32, 139-145, 1989.
33. Collier, D. H., Kerwar, S. S., Garovoy, M. R., Fye, K. H., and Stobo, J. D., Anticollagen antibodies and immune response gene products in rheumatoid arthritis. Arthritis Rheum. 27, 1201-1209, 1984.
34. Fujii, K., Tsuji, M., Murota, K., Terato, K., Shimozuru, Y., and Nagai, Y., An improved enzyme-linked immunosorbent assay of anti-collagen antibodies in human serum. J Immunol. Methods. 124, 63-70, 1989.
35. Upholt, W. B., and Sandell, L. J., Exon/intron organization of the chicken type II procollagen gene: Intron size distribution suggests a minimal intron size. Proc. Natl. Acad. Sci. USA 83, 2325-2329, 1986.
36. Kohno, K., Martin, G. R., and Yamada, Y., Structure of the promoter of the rat type II collagen gene. J. Biol. Chem. 260, 4441-4447, 1985.
37. Sangiorgi, F. O., Benson-Chanda, V., De Wet, W. J., Sobel, M. E., and Ramirez, F., Analysis of cDNA and genomic clones coding for the proα1 chain of calf type II collagen. Nucleic Acids Res. 13, 2815-2826, 1985.
38. Seyer, J. M., Hasty, K. A., and Kang, A. H., Covalent structure of collagen. Amino acid sequence of an arthritogenic cyanogen bromide peptide from type II collagen of bovine cartilage. Eur. J. Biochem. 181, 159-173, 1989.
39. Ryan, M. W., Sieraski, M., and Sandell, L. J., The human type II collagen gene: Identification of an additional protein-coding domain and location of potential regulatory sequences in the promotor and first intron. Genomics 8, 41-48, 1990.
40. Ala-Kokko, L., and Prockop, D. J., Completion of the intronexon structure of the gene for human type II collagen (COL 2A1): Variations in the nucleotide sequences of alleles from three chromosomes. Genomics 8, 454-460, 1990.
41. Baldwin, C. T., Reginato, A. M., Smith, C., Jimenez, S. A., and Prockop, D. J., Structure of cDNA clones coding for human type II procollagen. The α1(II) chain is more similar to the α1 (I) chain than other α chains of fibrillar collagen. Biochem. J. 262, 521-528, 1989.
42. Elima, K., Vourio T., and Vuorio E., Determination of the single polyadenylation site of the human proα(II) collagen gene. Nucleic Acids Res. 15, 9499-9504, 1987.
43. Terato, K., Hashida, R., Miyamoto, K., Morimoto, Y., Kato, Y., Kobayashi, S., Tajima, T., Otake, S., Hori, H., and Nagai, Y., Histological, immunological and biochemical studies on type II collagen-induced arthritisin rats. Biomed. Research. 3, 495-505, 1982.
44. Stuart, J. M., Townes, A. S., and Kang, A. H., Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J. Clin. Invest. 69, 673-683, 1982.
45. Terato, K., Hasty, K. A., Cremer, M. A., Stuart, J. M., Townes, A. S., and Kang, A. H., Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J. Exp. Med. 162, 637-646, 1985.
46. Terato, K., Arai, H., Shimozuru, Y., Fukuda, T., Tanaka, H., Watanabe, H., Nagai, Y., Fujimoto, K., Okubo, F., Cho, F., Honjo, S., and Cremer, M. A., Sex-linked differences in susceptibility of cynomolgus monkeys to type II collagen-induced arthritis. Arthritis Rheum. 32, 748-758, 1989.
47. Terato, K., Hasty, K. A., Reife, R., Cremer, M. A., Stuart, J. M., and Kang, A. H., Induction of arthritis with monoclonal antibodies to collagen. J. Immunol. 148, 2103-2108, 1992.
48. Hernandez, A. D., Cremer, M. A., Townes, A. S., Stuart, J. M., and Kang, A. H., The immuneresponse of guinea-pigs to type II collagen: Poor cross-reactivity with homologous type II collagen accounts for resistance to collagen-induced arthritis. Immunology 63, 619-624, 1988.
49. Brandtzaeg, P., and Baklien, K., Immunohistochemical studies of the formation and epithelial transport of immunoglobulins in normal and diseased human intestinal mucosa. Scand. J. Gastroenterol. 11(Suppl 36), 1-45, 1976.
50. Medsger, T. A. J., and Masai, A. T., Epidemiology of the rheumatic diseases. In "Arthritis and Allied Conditions" (D. McCarty, Ed.), 10th ed. Lea & Febiger, Philadelphia, 1985.
51. Miller, E. J., Isolation and characterization of the cyanogen bromide peptides from the a1(II) chain of chick cartilage collagen. Biochemistry 10, 3030-3035, 1971.
52. Cremer, M. A., Townes, A. S., and Kang, A. H., Collagen-induced arthritis in rodents. A review of clinical, histological and immunological features. Ryumachi 24, 45-56, 1984.
53. Charriere, G., Bejot, L., Ville, G., and Hartman, D., Reactions to a bovine collagen implant. J. Am. Acad. Dermatol. 6, 1203-1208, 1989.
54. Cremer, M. A., Terato, K., and Kang, A. H., Collagen autoimmunity in rheumatoid arthritis and relapsing polychondritis: Sera reactivity to homologous and heterologous type I and type II collagens. Arthritis Rheum. 32, S22, 1989.
55. O'Mahony, S., and Ferguson, A., Small intestinal mucosal protection mechanisms and their importance in rheumatology. Ann. Rheum. Dis. 50, 331-336, 1991.
56. Walker, W. A., Cornell, R., Davenport, L. M., and Isselbacher, K. J., Macromolecule absorption. Mechanism of horseradish peroxidase uptake and transport in adult and neonatal rat intestine. J. Cell. Biol. 54, 195-205, 1972.
57. Thompson, H. S., Henderson, B., Spencer, J. M., Hobbs, S. M., Peppard, J. V., and Staines, N. A., Tolerogenic activity of polymerized type II collagen in preventing collagen-induced arthritis in rats. Clin. Exp. Immunol. 72, 20-25, 1988.
58. Nagler-Anderson, C., Bober, L. A., Robinson, M. E., Siskind, G. W., and Thorbecke, G. J., Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci. USA 83, 7443-7446, 1986.
59. Thompson, H. S., and Staines, N. A., Gastric administration of type II collagen delays the on set and severity of collagen-induced arthritis in rats. Clin Exp Immunol. 64, 581-586, 1986.
60. Picker, L. J., Mechanisms of lymphocyte homing. Curr. Opin. Immunol. 4, 277-286, 1992.
61. Watson, W. C., Cremer, M. A., Wooley, P. H., and Townes, A. S., Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a. Arthritis Rheum. 29, 1316-1321, 1986.
62. Watson, W. C., Tooms, R. E., Carnesale, P. G., and Dutkowsky, J. P., A case of germinal center formation by CD45RO T and CD20B lymphocytes in rheumatoid arthritic subchondral bone: Proposal for a two-compartment model of immuno-mediated disease with implications for immunotherapeutic strategies. Clin. Immunol. Immunopathol. 73, 27-37, 1994.
63. Cole, B. C., and Griffiths, M. M., Triggering and exacerbation of autoimmune arthritis by the Mycoplasma Arthritidis superantigen MAM. Arthritis Rheum. 36, 994-1002, 1993.
64. Griffiths, M. M., Sawaitzke, A. D., Harper, D. S., McCall, S., Reese, V. S., and Cannon, G. W. Exacerbation of collagen-induced arthritis in rats by rat cytomegalovirus is antigen-specific. Autoimmunity 18, 177-187, 1994.
65. Terato, K., Harper, D. S., Griffiths, M. M., Hasty, D. L., Ye, X. Y., Cremer, M. A., and Seyer, J. M. Collagen-induced arthritis. Synergistic effect of E. coll lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. Autoimmunity, in press, 1996.
66. Trentham, D. E., Dynesius-Trentham, R. A., Orav, E. J., Combitchi, D., Lorenzo, C., Sewell, K. L., Hafler, D. A., and Weiner, H. L. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261, 1727-1730, 1993.